Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

'CDER director Tidmarsh will be acting head of FDA biologics center following Prasad exit'- Endpoints News

Author: Benzinga Newsdesk | July 30, 2025 12:28pm

https://endpoints.news/cder-director-tidmarsh-will-be-acting-head-of-fda-biologics-center-following-prasad-exit/

Posted In: REVB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist